Followers | 4 |
Posts | 243 |
Boards Moderated | 0 |
Alias Born | 05/31/2008 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 12, 2011 5:21:27 PM
Peer reviewed publications in a reputed journal is a different matter. Such a publication means that people who are knowledgeable have read the publication and agree with the methods and conclusions with the expectation that the authors are truthful. That still does not mean that the technology will work. However, it does mean that the peers have reviewed the methods used and agree with them. Look at the results published by NNVC. Nowhere I have seen how many animals were tested and how many confirmed the results shown. A paper giving such a result would never get published. That is why publication in a peer reviewed reputable journal gives the results credibility.
We need credibility for this stock to get it moving.
Another factor that I am not happy with is their reluctance to raise and spend money. Unless you spend money you cannot get results. We need quick results.
I am unhappy because the company has until now spent about $12 million in research. Their market cap is around $150 million. That means that when the company spends $1 their market value goes up by $10. Where can you ever get such a return? So I would say every year raise $10 million from stock sales and raise your market cap by $100.
This analysis is indicative of course. What they should really do is:
Announce results, stock price goes up, raise money, spend money wisely,
Repeat
If they do this continuously we will see price go up much faster.
There are a few other matters that I need to discuss. Seymore seems open to talking on phone. I will definitely call him next week.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM